SecSonar.com

Silo Pharma, Inc. (SILO)

Silo Pharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Silo Pharma, Inc. (SILO) is a Biotechnology company based in US with a market capitalization of $3.6M. Revenue grew 0.0% year-over-year and free cash flow was negative at -$4.7M. This page tracks SILO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3 employees · IPO Jan 8, 2021

Valuation

Valuation & price

$0.40 · as of May 17, 2026 · -96.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.57

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$11.95$8.11$4.27Jul 25Dec 25Jul 26Jul 7, 25$9.01Jul 9, 25$9.30Jul 11, 25$8.76Jul 15, 25$8.62Jul 17, 25$9.48Jul 21, 25$9.27Jul 23, 25$10.41Jul 25, 25$9.99Jul 29, 25$10.36Jul 31, 25$11.69Aug 4, 25$11.64Aug 6, 25$8.97Aug 11, 25$9.45Aug 13, 25$10.51Aug 15, 25$10.65Aug 19, 25$9.90Aug 21, 25$10.01Aug 25, 25$9.60Aug 27, 25$9.61Aug 29, 25$9.42Sep 3, 25$9.36Sep 5, 25$9.16Sep 9, 25$9.73Sep 11, 25$10.20Sep 16, 25$10.90Sep 18, 25$10.60Sep 22, 25$11.75Sep 24, 25$11.95Sep 26, 25$11.56Sep 30, 25$10.35Oct 2, 25$10.51Oct 6, 25$10.22Oct 8, 25$10.39Oct 10, 25$8.43Oct 14, 25$9.29Oct 16, 25$9.03Oct 21, 25$8.63Oct 23, 25$8.37Oct 27, 25$8.54Oct 29, 25$8.07Oct 31, 25$8.12Nov 4, 25$7.50Nov 6, 25$7.40Nov 10, 25$6.99Nov 12, 25$6.77Nov 14, 25$6.20Nov 18, 25$6.29Nov 20, 25$5.45Nov 25, 25$6.48Nov 28, 25$6.98Dec 2, 25$6.83Dec 4, 25$6.77Dec 8, 25$6.82Dec 10, 25$6.60Dec 12, 25$6.52Dec 16, 25$6.00Dec 18, 25$5.77Dec 22, 25$6.45Dec 24, 25$5.78Dec 29, 25$5.02Jan 2, 26$5.03Jan 6, 26$5.69Jan 8, 26$5.84Jan 12, 26$5.93Jan 14, 26$5.88Jan 16, 26$5.67Jan 21, 26$5.34Jan 23, 26$5.57Jan 27, 26$5.55Jan 29, 26$4.93Feb 2, 26$4.90Feb 4, 26$4.66Feb 9, 26$4.27Feb 11, 26$4.36Feb 13, 26$4.36Feb 18, 26$4.39Feb 20, 26$4.30Feb 24, 26$5.23Feb 26, 26$5.70Mar 2, 26$5.35Mar 4, 26$5.40Mar 6, 26$4.92Mar 10, 26$5.20Mar 12, 26$5.15Mar 17, 26$4.88Mar 19, 26$4.89Mar 23, 26$5.22Mar 25, 26$5.70Mar 27, 26$5.10Mar 31, 26$5.40Apr 2, 26$5.18Apr 7, 26$7.95Apr 9, 26$6.24Apr 13, 26$6.46Apr 15, 26$6.14Apr 17, 26$7.73Apr 22, 26$8.54Apr 24, 26$7.50Apr 28, 26$6.66Apr 30, 26$6.63May 4, 26$6.92May 6, 26$6.32May 8, 26$6.08May 12, 26$5.94May 14, 26$5.91May 18, 26$5.82May 20, 26$5.59May 22, 26$5.87May 28, 26$6.36Jun 1, 26$4.99Jun 3, 26$6.13Jun 5, 26$5.90Jun 9, 26$6.46Jun 11, 26$6.44Jun 15, 26$6.33Jun 17, 26$5.81Jun 22, 26$6.02Jun 24, 26$6.22Jun 26, 26$6.05Jul 2, 26$6.18
$4.2252-week range$12.23
Loading valuation history…

Fundamentals

Key fundamentals

$3.6M

Market cap

0.0%

Revenue growth (YoY)

-1128.9%

Gross margin

-$4.7M

Free cash flow (USD)

-$6.9M

Net debt

Net cash position

127.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$-669.5KFY 2017$847.4KFY 2018$0.00FY 2019$40.6KFY 2020$0.00FY 2021$71.3KFY 2022$72.1KFY 2023$72.1KFY 2024$72.1KFY 2025$72.1K
-$669.5K$72.1K

Free cash flow by year

2016 → 2025

FY 2016$-143.6KFY 2017$-284.6KFY 2018$272.6KFY 2019$-794.3KFY 2020$-1.2MFY 2021$-2.3MFY 2022$-3.5MFY 2023$-3.2MFY 2024$-3.8MFY 2025$-4.7M
-$143.6K-$4.7M

Gross margin by year

2021 → 2025

FY 202193.0%FY 202291.9%FY 202391.9%FY 202491.9%FY 2025-1128.9%
93.0%-1128.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventRegained Nasdaq ComplianceJun 18, 2026Filing
  • 8-K eventReverse Stock SplitJun 3, 2026Filing
  • 8-K eventReverse Stock SplitJun 1, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventAsset Purchase AgreementApr 2, 2026Filing

Questions

Frequently asked questions

What is Silo Pharma, Inc.'s market cap?

Silo Pharma, Inc. (SILO) has a market capitalization of $3.6M.

What is SILO's P/E ratio?

A meaningful P/E ratio is not available for SILO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SILO's price-to-book (P/B) ratio?

SILO trades at 0.57 times book value per share.

Are insiders buying SILO stock?

SEC Form 4 filings show no open-market insider buys at Silo Pharma, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CDIO

Cardio Diagnostics Holdings, Inc.

$3.7M

VIVS

VivoSim Labs, Inc.

$3.4M

ERNA

Ernexa Therapeutics Inc.

$3.4M

ELAB

PMGC Holdings Inc.

$3.4M

HCWB

HCW Biologics Inc.

$4.3M

INM

InMed Pharmaceuticals Inc.

$2.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.